U.S. Markets close in 1 hr 57 mins

Vifor Pharma AG (VIFN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
119.75-0.85 (-0.70%)
At close: 5:30PM CEST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in CHF

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.30
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3140.10
52 Week Low 399.68
50-Day Moving Average 3127.92
200-Day Moving Average 3128.04

Share Statistics

Avg Vol (3 month) 3175.5k
Avg Vol (10 day) 3209.51k
Shares Outstanding 564.86M
Implied Shares Outstanding 6N/A
Float 846.6M
% Held by Insiders 128.08%
% Held by Institutions 138.13%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 41.60%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 31.66%
5 Year Average Dividend Yield 41.51
Payout Ratio 461.16%
Dividend Date 3May 12, 2021
Ex-Dividend Date 4May 10, 2021
Last Split Factor 210:1
Last Split Date 3May 22, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2020
Most Recent Quarter (mrq)Dec 31, 2020

Profitability

Profit Margin 20.41%
Operating Margin (ttm)17.78%

Management Effectiveness

Return on Assets (ttm)3.86%
Return on Equity (ttm)6.13%

Income Statement

Revenue (ttm)1.76B
Revenue Per Share (ttm)27.16
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.06B
EBITDA 513.3M
Net Income Avi to Common (ttm)138.7M
Diluted EPS (ttm)5.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)734.4M
Total Cash Per Share (mrq)11.32
Total Debt (mrq)609.7M
Total Debt/Equity (mrq)15.18
Current Ratio (mrq)2.96
Book Value Per Share (mrq)55.04

Cash Flow Statement

Operating Cash Flow (ttm)423.8M
Levered Free Cash Flow (ttm)79.34M